Research

Mark Hamer on Clarivate's Highly Cited Researchers 2022
Professor Mark Hamer has been listed as one of the world's most influential researchers by Clarivate in their annual Highly Cited Researchers list for 2022.

Long-lasting COVID impact on children
Dr Snehal Pinto Pereira appeared on ITV News to discuss key findings from a new study in Lancet Europe about the long-lasting impacts of Covid-19 on children's health. See the clip.

Clinician scientist wins prestigious urology award
Dr Veeru Kasivisvanathan has been recognised by the European Association of Urology (EAU) with the Crystal Matula Award for remarkable achievements in advancing prostate cancer research.

REF 2021 Highlight: Single-dose radiotherapy transforms breast cancer patient care
Our clinicians have transformed breast cancer care by developing a single-dose radiotherapy treatment to be delivered in the same operation as tumour surgery.
Our work
3D Models of Health and Disease
Bioengineering & Surgical Technology
Biomaterials & Surgical Reconstruction
Kidney Cancer Research (Coming soon)
Precision Nano Systems & Advanced Therapy
Our research departments
Research services

Surgical Interventional Group (Clinical Trials)
SIG provides infrastructure for studies led by surgeons and interventionists within any anatomical site. It has history of managing large-scale multi-centre, multinational randomised controlled clinical trials in solid tumours.

Tissue Access for Patient Benefit
TAPb facilitates the access, storage, use and transfer of human organs, cells, and tissue between clinical centres within UCL and a range of institutions to help researchers access the materials they need.